Literature DB >> 22652144

[Intravenous thrombolysis in capsular warning syndrome: is it beneficial?].

B Gutiérrez Ruano1, A García Pastor, J A Villanueva Osorio, N Bravo Quelle, P Vázquez Alén, F Díaz Otero, A Gil Núñez.   

Abstract

Mesh：

Year:  2012        PMID： 22652144     DOI： 10.1016/j.nrl.2012.03.013

Source DB:  PubMed          Journal:  Neurologia        ISSN： 0213-4853            Impact factor:   3.109


× No keyword cloud information.
  3 in total

1.  rt-PA with Antithrombotic Therapies in a Case with Capsular Warning Syndrome.

Authors:  Yasuhiro Fuseya; Miyuki Kawamura; Eri Matsuda; Kozue Takada; Kiwamu Watanabe; Junko Fujitake; Yoshifumi Nakaya
Journal:  Intern Med       Date:  2017-02-15       Impact factor: 1.271

2.  Intravenous tirofiban therapy for patients with capsular warning syndrome.

Authors:  Wei Li; Ya Wu; Xiao-Shu Li; Cheng-Chun Liu; Shu-Han Huang; Chun-Rong Liang; Huan Wang; Li-Li Zhang; Zhi-Qiang Xu; Yan-Jiang Wang; Meng Zhang
Journal:  Stroke Vasc Neurol       Date:  2019-01-09

3.  Capsular warning syndrome: clinical analysis and treatment.

Authors:  Lanying He; Ronghua Xu; Jian Wang; Lili Zhang; Lijuan Zhang; Fangfang Zhou; Weiwei Dong
Journal:  BMC Neurol       Date:  2019-11-13       Impact factor: 2.474
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.